Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:15 PM
Ignite Modification Date:
2025-12-24 @ 2:15 PM
NCT ID:
NCT03944395
Eligibility Criteria:
Inclusion criteria:
Index clients:
* All index clients who are 18 years old or older (i.e., new positives, known positives not on treatment, and known positives who are on treatment), will be eligible for the study and eligible to receive VAPN services if informed consent is given.
* Index clients who are inpatients and pregnant women are eligible for inclusion in the study and in VAPN services if informed consent is given.
Contacts:
• All contacts of any age are eligible to be included in the study and eligible to receive HIV testing services according to Ministry of Health (MOH) guidelines. The age of consent to receive any component of HIV testing services in Malawi is 13. Prior to testing a contact (e.g., a child of an index case) who is \<13 years old, for HIV, the guardian's consent is needed, per MOH guidelines.
Exclusion criteria:
Index clients
* Did not consent
* Aged \<18 years old a
* Prisoners, Mentally disabled
* Intimate partner violence
* Cannot explain the three VAPN options (contract, referral, and dual referral) in a way that would result in true informed assent on the part of the client.
Contacts:
• There are no exclusion criteria for contacts to be included in the study or receive HIV testing services if they or their guardian desire services. Contacts who are \<13 years old will not be contacted by phone under any VAPN contact outreach scenario.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03944395
Study Brief:
Protocol Section:
NCT03944395